Published in Can J Infect Dis Med Microbiol on September 01, 2006
Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol (2009) 10.42
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07
The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis (2012) 3.26
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol (2008) 1.68
Contamination of environmental surfaces with Staphylococcus aureus in households with children infected with methicillin-resistant S aureus. JAMA Pediatr (2014) 1.55
Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol (2008) 1.43
Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol (2011) 1.30
Sensitivities of nasal and rectal swabs for detection of methicillin-resistant Staphylococcus aureus colonization in an active surveillance program. J Clin Microbiol (2008) 1.12
Whole-genome sequencing in outbreak analysis. Clin Microbiol Rev (2015) 1.03
Community-associated MRSA: superbug at our doorstep. CMAJ (2007) 1.01
Community-associated methicillin-resistant Staphylococcus aureus infections in men who have sex with men: A case series. Can J Infect Dis Med Microbiol (2007) 0.77
Clinical characteristics of pediatric patients hospitalized with methicillin-resistant Staphylococcus aureus in Canadian hospitals from 2008 to 2010. Can J Infect Dis Med Microbiol (2013) 0.75
Methicillin-resistant Staphylococcus aureus colonization among health care workers in a downtown emergency department in Toronto, Ontario. Can J Infect Dis Med Microbiol (2013) 0.75
Community-associated methicillin-resistant Staphylococcus aureus: Continuing to evolve. Can J Infect Dis Med Microbiol (2008) 0.75
Community-associated methicillin-resistant Staphylococcus aureus: Implications for the care of children. Can J Infect Dis Med Microbiol (2007) 0.75
Treatment of septic arthritis. CMAJ (2007) 0.75
Can methicillin-resistant Staphylococcus aureus prevalence from dairy cows in India act as potential risk for community-associated infections?: A review. Vet World (2017) 0.75
Prevention and control of infections in the home. CMAJ (2009) 0.75
Community-associated methicillin-resistant Staphylococcus aureus: Implications for the care of children. Paediatr Child Health (2007) 0.75
Control of antibiotic-resistant bacteria in the office and clinic. CMAJ (2009) 0.75
The increasing prevalence of clindamycin resistance in Staphylococcus aureus isolates in children with head and neck abscesses. Can J Infect Dis Med Microbiol (2011) 0.75
Targeting Alpha Toxin to Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia. Antimicrob Agents Chemother (2017) 0.75
Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol (2003) 16.45
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet (2006) 15.99
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A (2002) 15.85
Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis (2003) 13.83
Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med (2005) 12.75
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA (2003) 12.04
Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol (2002) 10.88
The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis (2001) 10.43
Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet (2002) 10.26
Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med (2006) 8.91
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med (2005) 8.39
Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis (2005) 6.94
Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis (2003) 6.88
A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med (2005) 6.14
Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13
Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis (2006) 5.92
Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis (2002) 5.75
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest (2003) 5.64
Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J (2004) 4.58
Community-associated MRSA--resistance and virulence converge. N Engl J Med (2005) 4.15
Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep (2003) 4.14
A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med (2006) 4.00
Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis (2005) 3.97
Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis (2005) 3.91
Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis (1995) 3.66
Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis (2005) 3.54
Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis (2002) 3.53
Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis (2004) 3.47
Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis (2005) 3.36
Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep (2003) 3.35
A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis (2004) 3.29
Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol (1994) 3.27
Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med (1991) 3.24
Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics (2005) 3.13
Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis (1991) 3.12
Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. MMWR Morb Mortal Wkly Rep (2001) 3.00
Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis (2003) 2.99
Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med (1998) 2.94
Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA (2001) 2.93
Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis (2003) 2.92
Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J (2004) 2.91
Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis (2003) 2.90
Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis (2004) 2.86
Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis (2003) 2.80
Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control (2002) 2.68
Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust (1996) 2.63
Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999. J Infect Dis (2002) 2.57
Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J (2002) 2.54
Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect (1993) 2.51
Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J (2002) 2.47
Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis (2004) 2.42
Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity. J Infect Dis (2005) 2.34
The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect (1994) 2.34
Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis (2004) 2.28
Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis (2005) 2.27
Methicillin-resistant Staphylococcus aureus in dogs and cats: an emerging problem? J Small Anim Pract (2004) 2.27
Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics (2006) 2.17
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14
Methicillin-resistant staphylococci in companion animals. Emerg Infect Dis (2005) 2.07
Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis (2005) 2.02
Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control (2005) 1.98
Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimicrob Agents Chemother (2004) 1.97
Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis (2005) 1.97
Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis (2004) 1.96
Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1999) 1.92
Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med (2006) 1.91
Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis (2005) 1.89
Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis (2003) 1.88
Role of antimicrobial applications to the umbilical cord in neonates to prevent bacterial colonization and infection: a review of the evidence. Pediatr Infect Dis J (2003) 1.76
An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg (2004) 1.76
Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis (2004) 1.76
Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J (2004) 1.75
Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect (1998) 1.72
Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada. J Clin Microbiol (2005) 1.70
Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol (2006) 1.69
An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol (2003) 1.68
Estimating the proportion of community-associated methicillin-resistant Staphylococcus aureus: two definitions used in the USA yield dramatically different estimates. J Hosp Infect (2005) 1.67
Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med (1999) 1.66
Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother (2002) 1.65
Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis (2005) 1.65
Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J (2001) 1.65
Guide to development of practice guidelines. Clin Infect Dis (2001) 1.61
Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J (2006) 1.60
Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis (2005) 1.59
Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics (2004) 1.52
Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland. Vet Microbiol (2005) 1.52
The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit. J Infect Dis (1982) 1.52
An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital. Vet Microbiol (2005) 1.50
Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr (2005) 1.47
Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Can J Infect Dis (2001) 1.43
Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics (2006) 1.41
Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes. Clin Microbiol Infect (2005) 1.39
Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns--Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep (2006) 1.39
Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. J Am Vet Med Assoc (2005) 1.37
Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis J (2005) 1.36
A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a native community. Can J Infect Dis (1990) 1.33
Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin-resistant Staphylococcus aureus isolates from a French hospital over an 11 year period. J Antimicrob Chemother (2004) 1.33
Staphylococcus aureus CC398: host adaptation and emergence of methicillin resistance in livestock. MBio (2012) 6.50
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation (2010) 4.00
Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis (2009) 3.86
Health benefits of dietary fiber. Nutr Rev (2009) 3.54
Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis (2010) 3.42
Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med (2012) 3.38
Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 3.13
Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ (2009) 3.11
Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother (2010) 3.00
Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ (2013) 2.73
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2009) 2.66
Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med (2011) 2.59
Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999. J Infect Dis (2002) 2.57
Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr (2003) 2.42
Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother (2004) 2.36
SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol (2008) 2.35
A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.32
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.30
Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.22
Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis (2007) 2.17
The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J (2004) 2.15
Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis (2006) 2.12
Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases). Vet Dermatol (2014) 2.12
Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol (2002) 2.11
Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ (2004) 2.11
Healthcare-associated influenza in Canadian hospitals from 2006 to 2012. Infect Control Hosp Epidemiol (2014) 2.06
Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis (2005) 2.03
Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study*. Crit Care Med (2012) 1.97
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance. PLoS Med (2011) 1.88
Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine (2010) 1.86
Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.84
Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.81
A critical review of the fluoroquinolones: focus on respiratory infections. Drugs (2002) 1.79
Guidelines for animal-assisted interventions in health care facilities. Am J Infect Control (2008) 1.78
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2003) 1.75
Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother (2005) 1.74
Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant (2005) 1.73
PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol (2005) 1.72
Sputum induction in routine clinical care of children with cystic fibrosis. J Pediatr (2010) 1.67
Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol (2004) 1.67
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.66
The glycylcyclines: a comparative review with the tetracyclines. Drugs (2004) 1.64
Burden of seasonal influenza in children with neurodevelopmental conditions. Pediatr Infect Dis J (2014) 1.63
Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J Clin Microbiol (2005) 1.61
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004. Pediatrics (2006) 1.59
SHEA/APIC Guideline: Infection prevention and control in the long-term care facility. Am J Infect Control (2008) 1.56
Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg Infect Dis (2009) 1.55
Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One (2011) 1.55
Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency. Pediatr Transplant (2007) 1.54
Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg (2004) 1.52
Pediatric injuries from needles discarded in the community: epidemiology and risk of seroconversion. Pediatrics (2008) 1.51
Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer (2009) 1.49
Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc (2011) 1.48
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Experimental Clostridium difficile enterocolitis in foals. J Vet Intern Med (2004) 1.47
Necrotizing fasciitis: a six-year experience. J Burn Care Res (2012) 1.47
Human herpesvirus 7 in pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer (2007) 1.46
Methicillin-resistant Staphylococcus aureus colonization in veterinary personnel. Emerg Infect Dis (2006) 1.46
A risk index for sternal surgical wound infection after cardiovascular surgery. Infect Control Hosp Epidemiol (2003) 1.46
Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population. Pediatr Transplant (2005) 1.45
Multi-locus variable number tandem repeat analysis for investigation of the genetic association of Clostridium difficile isolates from food, food animals and humans. Anaerobe (2011) 1.45
Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One (2012) 1.44
Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One (2010) 1.43
Pediatric Epstein-Barr Virus-Associated Encephalitis: 10-Year Review. J Child Neurol (2006) 1.41
Fever and respiratory distress in an 8-year-old boy receiving therapy for acute lymphoblastic leukemia. J Pediatr (2003) 1.39
The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada. Pediatr Infect Dis J (2009) 1.38
Factors influencing childhood influenza immunization. CMAJ (2003) 1.38
An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol (2002) 1.36
Antimicrobial drug use in veterinary medicine. J Vet Intern Med (2005) 1.33
Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol (2002) 1.32
Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene. PLoS One (2012) 1.31
Blastomycosis in Ontario, 1994-2003. Emerg Infect Dis (2006) 1.30
Risk factors for surgical-site infection following primary total knee arthroplasty. Infect Control Hosp Epidemiol (2004) 1.28
Access to vaccines: A call to action. Paediatr Child Health (2003) 1.27
Evaluation of a new chromogenic medium, MRSA select, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2006) 1.27
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study. Pediatr Infect Dis J (2002) 1.26
A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol (2012) 1.25
Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol (2003) 1.25
The role of colonization pressure in nosocomial transmission of methicillin-resistant Staphylococcus aureus. Am J Infect Control (2008) 1.25
Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003. CMAJ (2005) 1.24
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One (2012) 1.23
Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001. Pediatr Infect Dis J (2007) 1.23
Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physician (2006) 1.22
Longitudinal phylogenetic surveillance identifies distinct patterns of cluster dynamics. J Acquir Immune Defic Syndr (2010) 1.20
Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl (2013) 1.19
Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control (2004) 1.19
Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol (2004) 1.19